29 Jul 2022 , 01:33 AM
Cipla announced that lnvaGen Pharmaceuticals Inc wholly owned step-down subsidiary of the Company in USA has entered into a Share Repurchase Agreement on 25 July 2022 with Avenue Therapeutics Inc Avenue and Fortress Biotech Inc for sale of 5833333 shares representing 2593Percentage of equity stake on a fully diluted basis held in Avenue for a consideration of USD 3 million and an additional amount upto USD 4 million on satisfaction of certain conditions On completion of the repurchase Avenue shall cease to be an associate of the Company
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
